159 related articles for article (PubMed ID: 32827144)
1. Main Features of DNA-Based Vectors for Use in Lactic Acid Bacteria and Update Protocols.
Coelho-Rocha ND; Barroso FAL; Tavares LM; Dos Santos ESS; Azevedo V; Drumond MM; Mancha-Agresti P
Methods Mol Biol; 2021; 2197():285-304. PubMed ID: 32827144
[TBL] [Abstract][Full Text] [Related]
2. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
3. Lactic Acid Bacteria as Delivery Vehicle for Therapeutics Applications.
Batista VL; da Silva TF; de Jesus LCL; Tapia-Costa AP; Drumond MM; Azevedo V; Mancha-Agresti P
Methods Mol Biol; 2021; 2183():447-459. PubMed ID: 32959259
[TBL] [Abstract][Full Text] [Related]
4. Impact of a Plasmid DNA-Based Alphavirus Vaccine on Immunization Efficiency.
Lundstrom K
Methods Mol Biol; 2021; 2197():33-47. PubMed ID: 32827131
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer during surgical procedures with molecular surgical suture.
Huang D; Yu F; Jingrong L
Eur J Histochem; 2004; 48(2):111-4. PubMed ID: 15208077
[TBL] [Abstract][Full Text] [Related]
6. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.
Bermúdez-Humarán LG; Kharrat P; Chatel JM; Langella P
Microb Cell Fact; 2011 Aug; 10 Suppl 1(Suppl 1):S4. PubMed ID: 21995317
[TBL] [Abstract][Full Text] [Related]
7. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
Dietrich G; Spreng S; Gentschev I; Goebel W
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
[TBL] [Abstract][Full Text] [Related]
8. Use of attenuated bacteria as delivery vectors for DNA vaccines.
Daudel D; Weidinger G; Spreng S
Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
[TBL] [Abstract][Full Text] [Related]
9. General and specialized vectors derived from pBM02, a new rolling circle replicating plasmid of Lactococcus lactis.
Sánchez C; Mayo B
Plasmid; 2004 May; 51(3):265-71. PubMed ID: 15109833
[TBL] [Abstract][Full Text] [Related]
10. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A
Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
[TBL] [Abstract][Full Text] [Related]
11. Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health.
Levit R; Cortes-Perez NG; de Moreno de Leblanc A; Loiseau J; Aucouturier A; Langella P; LeBlanc JG; Bermúdez-Humarán LG
Gut Microbes; 2022; 14(1):2110821. PubMed ID: 35960855
[TBL] [Abstract][Full Text] [Related]
12. Construction of a new shuttle vector for DNA delivery into mammalian cells using non-invasive Lactococcus lactis.
Yagnik B; Padh H; Desai P
Microbes Infect; 2016 Apr; 18(4):237-44. PubMed ID: 26655884
[TBL] [Abstract][Full Text] [Related]
13. Eosinophils are the main cellular targets for oral gene delivery using Lactic acid bacteria.
Takahashi K; Orito N; Yanagisawa D; Yano A; Mori Y; Inoue N
Vaccine; 2020 Apr; 38(17):3330-3338. PubMed ID: 32197922
[TBL] [Abstract][Full Text] [Related]
14. A Hybrid Biological-Biomaterial Vector for Antigen Delivery.
Qi R; Hill A; Pfeifer BA
Methods Mol Biol; 2021; 2183():461-475. PubMed ID: 32959260
[TBL] [Abstract][Full Text] [Related]
15. Comparison of plasmid DNA preparation methods for direct gene transfer and genetic immunization.
Davis HL; Schleef M; Moritz P; Mancini M; Schorr J; Whalen RG
Biotechniques; 1996 Jul; 21(1):92-4, 96-9. PubMed ID: 8816242
[TBL] [Abstract][Full Text] [Related]
16. Multivalent DNA-based vectors for DNA vaccine delivery.
Roh YH; Lee K; Ye JJ; Luo D
Methods Mol Biol; 2014; 1143():159-79. PubMed ID: 24715288
[TBL] [Abstract][Full Text] [Related]
17. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
Anderson RJ; Schneider J
Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of plasmid-mediated transgene expression.
Fioretti D; Iurescia S; Rinaldi M
Methods Mol Biol; 2014; 1143():11-20. PubMed ID: 24715279
[TBL] [Abstract][Full Text] [Related]
19. Design of plasmid DNA constructs for vaccines.
Montgomery DL; Prather KJ
Methods Mol Med; 2006; 127():11-22. PubMed ID: 16988443
[TBL] [Abstract][Full Text] [Related]
20. [Immunogenicity of plasmid DNA and adenoviral vectors encoding HIV-1 subtype B env gene].
Yang HR; Zhang LF; Feng X; Yu SQ; Zhuang ZL; Li HX; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):415-7. PubMed ID: 21604562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
